v3.26.1
Shareholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 17, 2026
May 17, 2026
May 12, 2026
Mar. 26, 2026
Mar. 16, 2026
Jun. 30, 2026
Shareholders’ Equity [Line Items]            
Aggregate net proceeds           $ 2,837
RSU fair value           $ 114
Purchase price of per pre-funded warrant $ 2.9999          
Exercise price of such warrants reduced per share 3          
Expiration date           Jun. 18, 2031
Series B Warrants [Member]            
Shareholders’ Equity [Line Items]            
Gross proceeds of ordinary shares       $ 4,000    
Purchase of warrants           133,334
Exercise price of warrants (in Dollars per share)           $ 3
Series C Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants           133,333
Exercise price of warrants (in Dollars per share)           $ 3
Net proceeds from rights offering       $ 3,517    
Pre-Funded Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants [1]           1,833,334
Exercise price of warrants (in Dollars per share) [1]           $ 0.0001
Series D Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants           1,833,334
Exercise price of warrants (in Dollars per share)           $ 3
Series E Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants           1,833,334
Exercise price of warrants (in Dollars per share)           $ 3
Series D Warrants and Series E Warrant [Member]            
Shareholders’ Equity [Line Items]            
Exercise price of warrants (in Dollars per share) $ 3          
Chief Executive Officer [Member]            
Shareholders’ Equity [Line Items]            
Granted restricted share units         2,188  
Officer [Member]            
Shareholders’ Equity [Line Items]            
Granted restricted share units   13,333     3,333  
Restricted Stock Units (RSUs) [Member]            
Shareholders’ Equity [Line Items]            
RSU fair value           $ 92
Granted restricted share units         5,521  
Ordinary Shares [Member]            
Shareholders’ Equity [Line Items]            
Gross proceeds of ordinary shares           $ 3,054
Sale of ordinary shares       266,667    
Price per share       $ 15    
A.G.P./Alliance Global Partners [Member]            
Shareholders’ Equity [Line Items]            
Gross sales price percentage     3.00%      
Sale of stock amount (in Dollars)     $ 4,340      
2026 ATM [Member]            
Shareholders’ Equity [Line Items]            
Sale of ordinary shares           716,537
June 2026 Private Placement [Member]            
Shareholders’ Equity [Line Items]            
Gross proceeds of ordinary shares $ 5,500          
Net proceeds from rights offering $ 4,955          
June 2026 Private Placement [Member] | Series B Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants 133,334          
June 2026 Private Placement [Member] | Series C Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants 133,333          
Exercise price of warrants (in Dollars per share) $ 16.5          
March 2026 Financing [Member] | Series B Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants       266,667    
March 2026 Financing [Member] | Series C Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants       266,667    
Exercise price of warrants (in Dollars per share)       $ 16.5    
Securities Purchase Agreement [Member] | Pre-Funded Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants 1,833,334          
Exercise price of warrants (in Dollars per share) $ 0.0001          
Securities Purchase Agreement [Member] | Series D Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants 1,833,334          
Securities Purchase Agreement [Member] | Series E Warrants [Member]            
Shareholders’ Equity [Line Items]            
Purchase of warrants 1,833,334          
[1] See Note 11- Subsequent events for further information regarding pre-funded warrants exercise after period end.